Stocktoria
Sonoma Pharmaceuticals, Inc. SNOA
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-01-26
Sonoma Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 38.0% | 38.2% | 37.3% | 33.7% | 31.6% |
| Operating margin | -12.6% | -26.0% | -36.9% | -34.4% | -46.6% |
| Net margin | -16.3% | -24.2% | -38.0% | -38.8% | -40.3% |
| FCF margin | -21.1% | -1.2% | -18.8% | -48.4% | -34.7% |
| Return on assets | -22.7% | -25.2% | -32.8% | -31.7% | -27.0% |
| Return on equity | -102.6% | -78.4% | -78.8% | -64.6% | -58.5% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 2.50 | 3.09 | 3.37 | 3.71 | 2.82 |
| Revenue growth | 36.7% | 12.2% | -4.0% | 5.1% | -32.2% |
Source: SEC EDGAR filings · CIK 0001367083 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.